Sign in
4

Changes in Ownership

NEUROONE MEDICAL TECHNOLOGIES Corp Filed Acc 0001709738-25-000005

Business Development Director sold 11,019 shares at an average $0.66 ($7,306)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Christianson Mark Business Development Director 2025-05-19 Sale −8,006 $0.67 $5,330 283,485 D: show line 1 in the form
Christianson Mark Business Development Director 2025-05-20 Sale −3,013 $0.66 $1,976 280,472 D: show line 2 in the form
Open-market sales · 11,019 sh · avg $0.66 · $7,306
Loading xslF345X05/primary_doc.xml…